State Street’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.2M Sell
3,442,752
-528,980
-13% -$4.95M ﹤0.01% 1924
2025
Q1
$48.8M Buy
3,971,732
+54,216
+1% +$666K ﹤0.01% 1652
2024
Q4
$51.8M Buy
3,917,516
+146,690
+4% +$1.94M ﹤0.01% 1702
2024
Q3
$72.6M Buy
3,770,826
+148,491
+4% +$2.86M ﹤0.01% 1509
2024
Q2
$74.4M Sell
3,622,335
-1,197,259
-25% -$24.6M ﹤0.01% 1448
2024
Q1
$115M Sell
4,819,594
-196,630
-4% -$4.68M 0.01% 1216
2023
Q4
$108M Buy
5,016,224
+1,415,576
+39% +$30.6M 0.01% 1240
2023
Q3
$52.3M Sell
3,600,648
-553,413
-13% -$8.04M ﹤0.01% 1598
2023
Q2
$86.9M Buy
4,154,061
+287,831
+7% +$6.02M ﹤0.01% 1318
2023
Q1
$81.7M Buy
3,866,230
+217,767
+6% +$4.6M ﹤0.01% 1319
2022
Q4
$92.9M Buy
3,648,463
+1,031,026
+39% +$26.2M 0.01% 1201
2022
Q3
$62.9M Buy
2,617,437
+181,920
+7% +$4.37M ﹤0.01% 1436
2022
Q2
$46.9M Buy
2,435,517
+55,180
+2% +$1.06M ﹤0.01% 1688
2022
Q1
$41.4M Sell
2,380,337
-99,867
-4% -$1.74M ﹤0.01% 1889
2021
Q4
$54.3M Buy
2,480,204
+376,757
+18% +$8.25M ﹤0.01% 1751
2021
Q3
$40.2M Sell
2,103,447
-1,066,985
-34% -$20.4M ﹤0.01% 1972
2021
Q2
$54.4M Buy
3,170,432
+516,961
+19% +$8.88M ﹤0.01% 1781
2021
Q1
$59.3M Buy
2,653,471
+953,751
+56% +$21.3M ﹤0.01% 1613
2020
Q4
$37.8M Buy
1,699,720
+581,000
+52% +$12.9M ﹤0.01% 1820
2020
Q3
$16.5M Buy
1,118,720
+645,600
+136% +$9.53M ﹤0.01% 2144
2020
Q2
$7.01M Buy
473,120
+33,218
+8% +$492K ﹤0.01% 2595
2020
Q1
$4.83M Sell
439,902
-633
-0.1% -$6.94K ﹤0.01% 2645
2019
Q4
$3.87M Buy
440,535
+24,971
+6% +$219K ﹤0.01% 2964
2019
Q3
$3.1M Buy
415,564
+91,018
+28% +$680K ﹤0.01% 3035
2019
Q2
$3.02M Buy
324,546
+81,628
+34% +$760K ﹤0.01% 3067
2019
Q1
$1.28M Buy
242,918
+24,266
+11% +$127K ﹤0.01% 3288
2018
Q4
$973K Buy
218,652
+22,794
+12% +$101K ﹤0.01% 3333
2018
Q3
$1.58M Buy
195,858
+41,851
+27% +$338K ﹤0.01% 3325
2018
Q2
$1.08M Buy
154,007
+24,066
+19% +$169K ﹤0.01% 3392
2018
Q1
$1.85M Buy
129,941
+13,651
+12% +$194K ﹤0.01% 3199
2017
Q4
$1.02M Buy
116,290
+31,756
+38% +$278K ﹤0.01% 3352
2017
Q3
$991K Buy
84,534
+3,207
+4% +$37.6K ﹤0.01% 3379
2017
Q2
$1.14M Buy
81,327
+20,106
+33% +$281K ﹤0.01% 3311
2017
Q1
$841K Buy
61,221
+2,300
+4% +$31.6K ﹤0.01% 3301
2016
Q4
$422K Buy
58,921
+3,599
+7% +$25.8K ﹤0.01% 3413
2016
Q3
$840K Buy
55,322
+9,776
+21% +$148K ﹤0.01% 3225
2016
Q2
$448K Buy
+45,546
New +$448K ﹤0.01% 3404